|
1
|
Kindblom LG, Remotti HE, Aldenborg F and
Meis-Kindblom JM: Gastrointestinal pacemaker cell tumor (GIPACT):
Gastrointestinal stromal tumors show phenotypic characteristics of
the interstitial cells of Cajal. Am J Pathol. 152:1259–1269.
1998.PubMed/NCBI
|
|
2
|
Hirota S, Isozaki K, Moriyama Y, Hashimoto
K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M,
et al: Gain-of-function mutations of c-kit in human
gastrointestinal stromal tumors. Science. 279:577–580. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heinrich MC, Corless CL, Duensing A,
McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A,
Town A, et al: PDGFRA activating mutations in gastrointestinal
stromal tumors. Science. 299:708–710. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Demetri GD, von Mehren M, Blanke CD, Van
den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA,
Singer S, Janicek M, et al: Efficacy and safety of imatinib
mesylate in advanced gastrointestinal stromal tumors. N Engl J Med.
347:472–480. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tran T, Devila JA and El-Serag HB: The
epidemiology of malignant gastrointestinal stromal tumors: An
analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol.
100:162–168. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miettinen M and Lasota J: Gastrointestinal
stromal tumors: Review on morphology, molecular pathology,
prognosis, and differential diagnosis. Arch Pathol Lab Med.
130:1466–1478. 2006.PubMed/NCBI
|
|
7
|
Miettinen M, Makhlouf H, Sobin LH and
Lasota J: Gastrointestinal stromal tumors of the jejunum and ileum:
A clinicopathologic, immunohistochemical, and molecular genetic
study of 906 cases before imatinib with long-term follow-up. Am J
Surg Pathol. 30:477–489. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lord C, Ozgediz D and Cohen MJ: Image of
the month. Gastrointestinal stromal tumor. Arch Surg. 144:87–88.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Efremidou EI, Liratzopoulos N,
Papageorgiou MS and Romanidis K: Perforated GIST of the small
intestine as a rare cause of acute abdomen: Surgical treatment and
adjuvant therapy. Case report. J Gastrointestin Liver Dis.
15:297–299. 2006.PubMed/NCBI
|
|
10
|
Bardell T, Jalink DW, Hurlbut DJ and
Mercer CD: Gastrointestinal stromal tumour: Varied presentation of
a rare disease. Can J Surg. 49:286–289. 2006.PubMed/NCBI
|
|
11
|
Chen HW and Lin TY: Tumor abscess
formation caused by Morganella morganii complicated with bacteremia
in a patient with gastrointestinal stromal tumor. Clin Res Hepatol
Gastroenterol. 36:e29–e31. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Karagülle E, Türk E, Yildirim E, Gõktürk
HS, KiYici H and Moray G: Multifocal intestinal stromal tumors with
jejunal perforation and intra-abdominal abscess: Report of a case.
Turk J Gastroenterol. 19:264–267. 2008.PubMed/NCBI
|
|
13
|
Dow N, Giblen G, Sobin LH and Miettinen M:
Gastrointestinal stromal tumors: Differential diagnosis. Semin
Diagn Pathol. 23:111–119. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rubin BP: Gastrointestinal stromal
tumours: An update. Histopathology. 48:83–96. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fletcher CD, Berman JJ, Corless C,
Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti
H, Rubin BP, et al: Diagnosis of gastrointestinal stromal tumors: A
consensus approach. Hum Pathol. 33:459–465. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miettinen M and Lasota J: Gastrointestinal
stromal tumors: Pathology and prognosis at different sites. Semin
Diagn Pathol. 23:70–83. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takahashi T, Nakajima K, Nishitani A,
Souma Y, Hirota S, Sawa Y and Nishida T: An enhanced risk-group
stratification system for more practical prognostication of
clinically malignant gastrointestinal stromal tumors. Int J Clin
Oncol. 12:369–374. 2007. View Article : Google Scholar : PubMed/NCBI
|
